HCA Healthcare, Inc., through its subsidiaries, operates as a health care services company in the United States. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. It also operates psychiatric hospitals, which provide therapeutic programs comprising child, adolescent and adult psychiatric care, and adolescent and adult alcohol and drug abuse treatment and counseling. In addition, the company operates outpatient health care facilities consisting of freestanding ambulatory surgery centers, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, rehabilitation and physical therapy centers, radiation and oncology therapy centers, physician practices, and various other facilities. As of December 31, 2020, it operated 185 hospitals, which included 178 general, acute care hospitals, as well as five psychiatric hospitals and two rehabilitation hospitals; 121 freestanding surgery centers; and 21 freestanding endoscopy centers in 20 states and England. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
IPO Year: 2011
Exchange: NYSE
Website: hcahealthcare.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/22/2024 | Outperform → Mkt Perform | Raymond James | |
| 10/11/2024 | $475.00 | Overweight | KeyBanc Capital Markets |
| 9/3/2024 | $427.00 | Equal-Weight | Morgan Stanley |
| 5/30/2024 | $396.00 | Outperform | Robert W. Baird |
| 3/6/2024 | $356.00 | Overweight | Barclays |
| 1/4/2024 | $277.00 → $301.00 | Outperform → Mkt Perform | Bernstein |
| 12/11/2023 | $271.00 | Buy → Neutral | Goldman |
| 4/21/2023 | $304.00 | Overweight | Cantor Fitzgerald |
| 4/19/2023 | $257.00 → $283.00 | Neutral | JP Morgan |
| 7/6/2022 | $233.00 → $160.00 | Market Perform → Underperform | BMO Capital Markets |
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it collected 21,137 pounds of unused or expired medications during its sixth annual "Crush the Crisis" national prescription drug take back day. This surpasses last year's totals and is the most the organization has ever collected during the annual event. In total, HCA Healthcare has now collected more than 88,600 pounds of medication since launching "Crush the Crisis" as an enterprise initiative in 2019. "I am amazed by the results of this year's Crush the Crisis," said Dr. Randy Fagin, chief medical officer of HCA Healthcare's National Group. "Our colleagues showed up for their commun
In honor of Veterans Day, HCA Healthcare to give $150,000 in support of veterans and their families HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that it has been recognized for the fifth consecutive year as a Best for Vets Employer by Military Times for its efforts to recruit, mentor and retain U.S. service members. HCA Healthcare has hired more than 65,000 veterans, active-duty and reserve personnel and military spouses since 2012. Additionally, HCA Healthcare has been nationally recognized as a Military Friendly and Military Spouse Friendly employer by VIQTORY for the 14th consecutive year and this year earned the Gold distinction
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene) Adjusted EBITDA totaled $3.267 billion Cash flows from operating activities totaled $3.515 billion Same facility admissions increased 4.5 percent and same facility equivalent admissions increased 4.5 percent "Our people recently,
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced it will host its sixth annual "Crush the Crisis" national prescription drug take back day on Saturday, Oct. 26, 2024. This year, 133 HCA Healthcare facilities across the country will partner with local law enforcement to help communities safely and anonymously dispose of unused or expired medications. Held each year, in alignment with the Drug Enforcement Administration's (DEA) National Prescription Drug Take Back Day, HCA Healthcare holds "Crush the Crisis" events to raise awareness about the dangers of prescription drug misuse and the importance of proper disposal of unused or expired medic
HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences: November 14, 2024 at 7:15am PT at the 2024 UBS Global Healthcare Conference at the Terranea Resort in Ranchos Palos Verdes, CA. November 20, 2024 at 11:20am ET at the 2024 Wolfe Research Healthcare Conference at the Wolfe Offices in New York, NY. November 21, 2024 at 8:00am CT at the 2024 Stephens Annual Investment Conference at the Grand Hyatt in Nashville, TN. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be s
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 25, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20240926343840
HCA Healthcare, Inc. (NYSE:HCA), is scheduled to present at the following healthcare conferences: September 5, 2024 at 8:00am ET at the 2024 Wells Fargo Healthcare Conference at the Encore Boston Arbor in Everett, MA. September 5, 2024 at 3:20pm ET at Morgan Stanley's 22nd Annual Global Healthcare Conference at the Marriott Marquis in New York, NY. A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company's website, www.hcahealthcare.com. Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company's web
HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including maturity, interest rate and principal amount, will depend on market conditions at the time of pricing. HCA Inc. intends to use the net proceeds from this offering for general corporate purposes, which may include the repayment of borrowings outstanding under its senior secured asset-based revolving credit facility. Citigroup Global Markets Inc., BofA Securities, Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC are acting as the joint book-running managers for the o
Raises 2024 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage changes compare 2Q 2024 to 2Q 2023 unless otherwise noted): Revenues totaled $17.492 billion Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted share Adjusted EBITDA totaled $3.550 billion Cash flows from operating activities totaled $1.971 billion Same facility admissions increased 5.8 percent while same facility equivalent admissions increased 5.2 percent "The company's results for the second quarter were positive and reflected strong demand
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q Earnings Release Call When: Tuesday, July 23, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/hom
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
4 - HCA Healthcare, Inc. (0000860730) (Issuer)
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
FWP - HCA Healthcare, Inc. (0000860730) (Subject)
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
10-Q - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
8-K - HCA Healthcare, Inc. (0000860730) (Filer)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
SC 13G/A - HCA Healthcare, Inc. (0000860730) (Subject)
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that the HCA Healthcare Foundation has helped Girl Scouts of the USA (GSUSA) launch a new series of Mental Wellness Patch Programs to address mental wellness among girls in 4th through 12th grade. This is a result of the HCA Healthcare Foundation's $1.38 million grant to GSUSA, through its Healthier Tomorrow Fund, which was announced last year. "The HCA Healthcare Foundation has a long history of partnering with Girl Scouts nationally and locally. We are proud to deepen our partnership with Girl Scouts on this research-based mental wellness program," said Joanne Pulles, vice president of com
HCA Healthcare, Inc. (NYSE:HCA) today announced Jyric Sims, Ph.D., will become president of the company's West Florida Division, effective June 12. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230420005364/en/Jyric Sims, Ph.D. (Photo: Business Wire) Sims, who currently is CEO of HCA Healthcare's Medical City Plano and Medical City Frisco hospitals, will succeed Ravi Chari, M.D., who recently announced he will retire after 15 years with the company to pursue opportunities in early-stage healthcare companies. A more than 20-year healthcare veteran, Sims has been with HCA Healthcare since 2011. He has served as chief executive
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that Chuck Hall, HCA Healthcare's National Group president, will retire at the end of the year after nearly 36 years with the organization. Currently, Hall is responsible for HCA Healthcare's operations at 96 hospitals across 13 states. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220817005233/en/HCA Healthcare Announces Retirement of Longtime Senior Executive Chuck Hall (Photo: Business Wire) Over more than three decades, Hall has been influential in many successful initiatives that will benefit the company for years to come, inc
HCA Healthcare, Inc. (NYSE:HCA), one of the nation's leading healthcare providers, today announced that its board of directors has appointed Andrea B. Smith as an independent director. With her addition effective today, HCA Healthcare's board of directors increases from 10 to 11 members. Ms. Smith will serve as a member of HCA Healthcare's audit and compliance committee as well as the patient safety and quality of care committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220126005165/en/HCA Healthcare Appoints Andrea Smith as New Independent Director (Photo: Business Wire) Ms. Smith most recently served as Bank of America's
HCA Healthcare, Inc. (NYSE:HCA) today announced that its board of directors has appointed Hugh F. Johnston as an independent director, effective September 1, 2021. With his addition, HCA Healthcare's board of directors increases from 9 to 10 members. Mr. Johnston will also serve as a member of HCA Healthcare's audit and compliance committee and finance and investments committee. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210727005288/en/HCA Healthcare Appoints Hugh F. Johnston as New Independent Director (Photo: Business Wire) Mr. Johnston is vice chairman and chief financial officer of PepsiCo, Inc., a global food and bevera
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Baird increased Apple Inc. (NASDAQ:AAPL) price target from $200 to $240. Baird analyst William Power maintained an Outperform rating. Apple shares fell 0.1% to trade at $218.51 on Thursday. See how other analysts view this stock. Truist Securities raised the price target for ServiceNow, Inc. (NYSE:NOW) from $750 to $780. Truist Securities analyst Joel Fishbein maintained a Hold rating. ServiceNow shares gained 11.9% to trade at $817.75 on Thursday. See how other analysts view this stock. JP Morg
Cantor Fitzgerald analyst Sarah James maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $335 to $392.
Cantor Fitzgerald analyst Sarah James reiterates HCA Healthcare (NYSE:HCA) with a Overweight and maintains $335 price target.
RBC Capital analyst Ben Hendrix maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $329 to $378.
Barclays analyst Andrew Mok maintains HCA Healthcare (NYSE:HCA) with a Overweight and raises the price target from $376 to $396.
Leerink Partners maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $367 to $396.
Truist Securities analyst David Macdonald maintains HCA Healthcare (NYSE:HCA) with a Buy and raises the price target from $375 to $390.
Oppenheimer analyst Michael Wiederhorn maintains HCA Healthcare (NYSE:HCA) with a Outperform and raises the price target from $345 to $390.
On Tuesday, HCA Healthcare Inc. (NYSE:HCA) reported second-quarter revenues of $17.49 billion, up from $15.86 billion a year ago and beating the consensus of $17.05 billion. The hospital chain reported adjusted EPS of $5.50, up from $4.29 a year ago, beating the consensus of $5.36. “The company’s results for the second quarter were positive and reflected strong demand for our services,” said Sam Hazen, Chief Executive Officer of HCA Healthcare. In the second quarter of 2024, same-facility admissions increased 5.8% year over year, while same-facility equivalent admissions increased 5.2%. Same-facility emergency room visits increased by 5.5%. Same-facility inpatient surgeries incre
- Conference Call
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2024. Key third quarter metrics (all percentage changes compare 3Q 2024 to 3Q 2023 unless otherwise noted): Revenues totaled $17.487 billion Net income attributable to HCA Healthcare, Inc. totaled $1.270 billion, or $4.88 per diluted share (which includes an estimated $0.15 per diluted share unfavorable impact from Hurricane Helene) Adjusted EBITDA totaled $3.267 billion Cash flows from operating activities totaled $3.515 billion Same facility admissions increased 4.5 percent and same facility equivalent admissions increased 4.5 percent "Our people recently,
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Friday, October 25, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/home/20240926343840
Raises 2024 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the second quarter ended June 30, 2024. Key second quarter metrics (all percentage changes compare 2Q 2024 to 2Q 2023 unless otherwise noted): Revenues totaled $17.492 billion Net income attributable to HCA Healthcare, Inc. totaled $1.461 billion, or $5.53 per diluted share Adjusted EBITDA totaled $3.550 billion Cash flows from operating activities totaled $1.971 billion Same facility admissions increased 5.8 percent while same facility equivalent admissions increased 5.2 percent "The company's results for the second quarter were positive and reflected strong demand
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 2Q Earnings Release Call When: Tuesday, July 23, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news/hom
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the first quarter ended March 31, 2024. Key first quarter metrics (all percentage changes compare 1Q 2024 to 1Q 2023 unless otherwise noted): Revenues totaled $17.339 billion Net income attributable to HCA Healthcare, Inc. totaled $1.591 billion, or $5.93 per diluted share Adjusted EBITDA totaled $3.353 billion Cash flows from operating activities totaled $2.469 billion Same facility admissions increased 6.2 percent while same facility equivalent admissions increased 5.2 percent "The strong fundamentals we saw in our business this past year continued into the first quarter of 2024. This m
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 1Q Earnings Release Call When: Friday, April 26, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.co
Bill Rutherford to Retire and Mike Marks to Become CFO HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the fourth quarter ended December 31, 2023. Key fourth quarter metrics (all percentage changes compare 4Q 2023 to 4Q 2022 unless otherwise noted): Revenues totaled $17.303 billion Net income attributable to HCA Healthcare, Inc. totaled $1.607 billion, or $5.93 per diluted share Adjusted EBITDA totaled $3.618 billion Cash flows from operating activities totaled $2.674 billion Same facility admissions increased 3.1 percent while same facility equivalent admissions increased 3.9 percent "In the quarter, we experienced strong demand for
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 4Q Earnings Release Call When: Tuesday, January 30, 2024 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com/news
Revises 2023 Guidance HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2023. Key third quarter metrics (all percentage changes compare 3Q 2023 to 3Q 2022 unless otherwise noted): Revenues totaled $16.213 billion Net income attributable to HCA Healthcare, Inc. totaled $1.079 billion, or $3.91 per diluted share Adjusted EBITDA totaled $2.880 billion Cash flows from operating activities totaled $2.479 billion Same facility admissions increased 3.4 percent while same facility equivalent admissions increased 4.1 percent "During the quarter, most aspects of our business were positive, including continue
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast: What: HCA Healthcare, Inc. 3Q Earnings Release Call When: Tuesday, October 24, 2023 at 9:00 am central (10:00 am eastern) How: Live Audio over the Internet: https://investor.hcahealthcare.com/events-and-presentations/default.aspx Contact: Frank Morgan, 615-344-2688, Vice President, Investor Relations, [email protected] If you are unable to listen during the live webcast, the call will be archived on the web site https://investor.hcahealthcare.com/events-and-presentations/default.aspx. View source version on businesswire.com: https://www.businesswire.com
Raymond James downgraded HCA from Outperform to Mkt Perform
KeyBanc Capital Markets initiated coverage of HCA with a rating of Overweight and set a new price target of $475.00
Morgan Stanley initiated coverage of HCA with a rating of Equal-Weight and set a new price target of $427.00
Robert W. Baird initiated coverage of HCA with a rating of Outperform and set a new price target of $396.00
Barclays initiated coverage of HCA with a rating of Overweight and set a new price target of $356.00
Bernstein downgraded HCA from Outperform to Mkt Perform and set a new price target of $301.00 from $277.00 previously
Goldman downgraded HCA from Buy to Neutral and set a new price target of $271.00
Cantor Fitzgerald initiated coverage of HCA with a rating of Overweight and set a new price target of $304.00
JP Morgan resumed coverage of HCA with a rating of Neutral and set a new price target of $283.00 from $257.00 previously
BMO Capital Markets downgraded HCA from Market Perform to Underperform and set a new price target of $160.00 from $233.00 previously